Tyra Biosciences, Inc.
Tyra Biosciences, Inc.（TYRA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · TYRA · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
14
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Tyra Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
TYRA 季度内部人买卖趋势
TYRA 内幕交易卖出 · TYRA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · TYRA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
TYRA 高管卖出股份 · TYRA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 5, 2026 | Warner Douglas J Chief Medical Officer | Award | 25,000 | — | Form 4 |
| May 5, 2026 | Fuhrman Alan CFO | Award | 20,000 | — | Form 4 |
| May 5, 2026 | Harris Todd President and CEO · Director | Award | 79,000 | — | Form 4 |
| May 5, 2026 | Ashar Bhavesh COO | Award | 15,013 | — | Form 4 |
| May 5, 2026 | Rueb Yuliya Vice President, Finance (PAO) | Award | 8,333 | — | Form 4 |
| Mar 26, 2026 | KAPLAN GILLA Director | Option | 53,172 | $120K | Form 4 |
| Mar 25, 2026 | KAPLAN GILLA Director | Option | 14,295 | $32K | Form 4 |
| Mar 25, 2026 | KAPLAN GILLA Director | Sale | 14,295 | $529K | Form 4 |
| Mar 26, 2026 | KAPLAN GILLA Director | Other | 53,172 | $2.01M⚡ | Form 4 |
| Mar 13, 2026 | Fuhrman Alan CFO | Award | 1,376 | $13K | Form 4 |
| Mar 13, 2026 | Harris Todd President and CEO · Director | Award | 1,463 | $13K | Form 4 |
| Feb 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 2,128 | $67K | Form 4 |
| Feb 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 5,872 | $196K | Form 4 |
| Jan 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 6,983 | $199K | Form 4 |
| Jan 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 1,017 | $30K | Form 4 |
| Dec 19, 2025 | MORE ROBERT J Director | Sale | 10,000 | $250K | Form 4 |
| Dec 12, 2025 | Bensen Daniel Chief Discovery Officer | Sale | 8,000 | $181K | Form 4 |
| Nov 21, 2025 | MORE ROBERT J Director | Sale | 246,871 | $5.00M⚡ | Form 4 |
| Nov 18, 2025 | Bensen Daniel COO | Sale | 75,633 | $1.22M⚡ | Form 4 |
| Nov 19, 2025 | Bensen Daniel COO | Sale | 49,956 | $815K | Form 4 |
| Nov 13, 2025 | Bensen Daniel COO | Sale | 1,111 | $18K | Form 4 |
| Nov 14, 2025 | Bensen Daniel COO | Sale | 110,228 | $1.77M⚡ | Form 4 |
| Nov 17, 2025 | Bensen Daniel COO | Sale | 18,572 | $299K | Form 4 |
| Nov 17, 2025 | Bensen Daniel COO | Sale | 1,500 | $26K | Form 4 |
| Sep 15, 2025 | Fuhrman Alan CFO | Award | 701 | $6K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 TYRA 内幕交易
TYRA 内幕交易
Tyra Biosciences, Inc.（TYRA）内幕交易数据来源于公司内部人（包括Bensen Daniel (Chief Discovery Officer), KAPLAN GILLA (Director), Fuhrman Alan (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。TYRA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Tyra Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
TYRA 内幕交易 · 5个问题Tyra Biosciences, Inc.（TYRA）的内部人包括高管和董事，如Bensen Daniel (Chief Discovery Officer), KAPLAN GILLA (Director), Fuhrman Alan (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026